European Registry Update

Slides:



Advertisements
Similar presentations
Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
Advertisements

ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs. Everolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions Julinda Mehilli,
The AiMI Trial Arshad Ali, MD, David Cox, MD, Nabil Dib, MD, Bruce Brodie, MD, Daniel Berman, MD, Navin Gupta, MD, Kevin Browne, MD, Robert Iwaoka, MD,
WG Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
ICE Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Angiographic Estimates of Myocardium at Risk During Acute Myocardial Infarction: a Validation Study Using Cardiac MRI José T. Ortiz, Sheridan N. Meyers,
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Featuring CTO Complex-PCI by Trans-radial Approach CTO Case review 5 French TRI CTO of right coronary artery -5 F Launcher guiding Catheter (right Judkins.
Maurizio Menichelli MD San Camillo Hospital, Rome ( SESAMI Trial) Maurizio Menichelli Presenter Disclosure Information Nothing to Disclose Randomized trial.
Retrograde approach for the Recanalizaiton of Coronary CTO: Preliminary Experience of Single Centre Lei Ge, Juying Qian, Xuebo Liu, Qin Qing, Junbo Ge.
Endeavor Safety: Pooled Analysis of Early and Late Safety of a Zotarolimus-Eluting Stent Laura Mauri, MD, MSc Brigham and Women’s Hospital Harvard Clinical.
ΕΚΕ Hellenic PCI Registry ( ) Περιεχόμενο και αναγκαιότητα διατήρησης Registry Αγγειοπλαστικής Georgios.
TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
MUSTELA : A Prospective, Randomized Trial of Thrombectomy vs. no Thrombectomy in Patients with ST-Segment Elevation Myocardial Infarction and Thrombus-Rich.
The SAFER Trial Evaluation of the Clinical Safety and Efficacy of the PercuSurge GuardWire in Saphenous Vein Graft Intervention As presented at TCT 2000.
The role of BVS in CTO PCI : Mid-term Clinical Outcomes with Multi-imaging Techniques CTO NYC 2016 Yaron Almagor M.D. Antonio Serra M.D. Director Interventional.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
Final 5 year results from the all-comer COMPARE trial: a prospective randomized comparison between Xience-V and Taxus Liberté TCT 2013 San Francisco Pieter.
Durable Polymer DES: 5 Year Outcomes RESOLUTE Update Sigmund Silber, MD FESC, FACC, FAHA Heart Center at the Isar Munich, Germany On Behalf of the RESOLUTE.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
The Endocross Enabler-P: First in-Human Results
European Registry Update
G. Capretti, M. Carlino, A. Colombo, L. Azzalini
Detroit Cardiogenic Shock Initiative
Transradial Intervention: Complex Case Review Yes, They Can Be Done!
What´s New in the Literature on Transradial Intervention
Nico H.J. Pijls, William F. Fearon, Peter Jüni, and Bernard De Bruyne
Updates From NOTION: The First All-Comer TAVR Trial
Advanced CTO Techniques:
Final Five-Year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients With Three-Vessel Disease and/or Left Main Disease Patrick.
Use of Laser When the Balloon Cannot Cross
The Radial Approach for CTO PCI Utility in the Retrograde and the Antegrade Approaches Shigeru Saito, MD, FACC, FSCAI, FJCC Shonan Kamakura General Hospital.
Carotid Artery Stenting Predictors of procedural and clinical success
Giuseppe Tarantini MD, PhD
Alexandra Lansky, MD Professor of Medicine, Section of Cardiology
Procedural factors associated with PCI-related ischemic stroke
SFA Access for TASC D lesions.
Vladimir Ganyukov, MD, PhD
BVS Expand: First Results of Wide Clinical Applications
Overview of the Clinical Utility of IVUS to Optimize PCI
Subintimal Tracking and Reentry for CTO STAR Method
The Hybrid approach to CTO PCI
Interesting Case Review
CTO Recanalization Highlights from TOPIC Meeting
Essesntials for CTO Recanalization
MACE Trial Rationale, Study Design, and Current Status
On behalf of J. Belardi, M. Leon, L. Mauri,
Presented by Dr. Leif Thuesen
Using Coronary CTA to Guide Intervention for CTO
Bern-Rotterdam Registry Published in the Lancet
American College of Cardiology Presented by Dr. Stephan Windecker
The Time Dependence of Anti-thrombin Initiation in Patients with Non-ST-segment –elevation Acute Coronary Syndrome: Subgroup Analysis form the ACUITY.
European Society of Cardiology 2003
Giuseppe Biondi Zoccai, MD
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD, MPH, FACC,
12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting.
No Financial Disclosure or Conflict of Interest
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Updated 3-Year Meta-Analysis of the TAXUS Clinical Trials Safety and Efficacy Demonstrated in 3,445 Randomized Patients Time allocation for this talk.
Maintenance of Long-Term Clinical Benefit with
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
Atlantic Cardiovascular Patient Outcomes Research Team
The American College of Cardiology Presented by Dr. A. Abazid
Presentation transcript:

European Registry Update Georgios Sianos, MD, PhD, FESC Aristotle University, AHEPA University Hospital Thessaloniki, Greece

Disclosure Statement of Financial Interest I, Georgios Sianos, DO NOT have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation. All CTO 2015 faculty disclosures are listed on the CRF Events App.

Euro CTO Club Membership

Web based ERCTO Registry

Online Registry 2008-2014

Antegrade /Retrograde Operators N=24 N=29 N=35 N=44 N=48 N=48 N=42

Antegrade /Retrograde Procedures

Angiographic Success %

Angiographic Success %

Procedural Success by JCTO Score according to Experience in Retrograde % Low = <50 procedure retrograde Moderate = 50-100 retrograde Good = >100 retrograde

Multivariate logistic regression analysis associated with technical failure in retrograde approach Variable OR 95% CI p-value Age, per 10-yr increase 1.19 1.04-1.36 0.01 Men 0.70 0.47-1.05 0.08 Diabetes 1.16 0.86-1.55 0.33 Ejection fraction <35% 0.89 0.50-1.58 0.68 History of MI, % 0.91 0.68-1.21 0.50 History of CABG, % 1.22 0.86-1.74 0.26 Prior PCI, % 0.98 0.74-1.29 0.87 Occlusion duration <12 months 0.95 0.80-1.12 0.55 Occlusion length < 20 mm 1.00 0.62-1.64 0.99 Operator Experience <50 versus >100 50-100 versus >100 3.07 2.17 2.19-4.30 1.52-3.10 <0.0001 J-CTO Score Intermediate versus very difficult Medium difficult versus very difficult Quite difficult versus very difficult 0.44 0.42 0.61 0.25-0.77 0.28-0.62 0.44-0.85

Wires to start %

Wires to start (Fielder XT Family) %

Final wires %

Guiding Catheter Selection in the ERCTO % 53,8 49,8 49,8 48,5 48,3 45,8 43,5 40,9 37,8 35,4 15,6 10,9 8,7 7,4 7,9 2010 2011 2012 2013 2014 6 French 7 French 8 French No trend differences were observed between antegrade and retrograde approach during years

Procedural Details % Controlateral injection Radial approach 2010 2011 61,6 54,4 53,7 49,4 47,2 17,5 15,7 15 12,2 8,6 2010 2011 2012 2013 2014 Controlateral injection Radial approach

Use of Dedicated Devices %

IVUS %

Procedural Complications Death Cardiac tamponade Myocardial infarction Vascular complication Coronary perforation Donor vessel dissection

Credibility check of the online EuroCTO-registry 2008-14 Logical checks on data ( predefined value ranges) Logical consistency-tests with respect to other data fields Automatic warnings when data are missing Courtesy C Reifart

2015 and on 10 % reabstraction of CTO records (n = 250/ year), masked and reviewed by a second abstractor

At random : „ your patient was selected for monitoring“ Automatic export of registry parameters 9 parameters to be checked by reviewer

CD will automatically be uploaded (Videoloader) It automatically stores all files to prepare Operator

At least 4 cineruns to be uploaded CTO vessel with retrograde/antegrade distal filling; Wire passage If applicable also for retrograde access Final result showing residual lesion and runoff.

Add requested runs to file

Any run can be played at high resolution and be reviewed

1 2 3 4 7 5/ 6

8 9

Monitor The monitor will evaluate the case in a structured way that finally  results in an agreement agreement with slight differences or relevant disagreement (i.e. no CTO or no TIMI 3 flow)

Test: Operator NR Monitor GW

Calculated accordance 84 %

Summary: ERCTO-Monitoring Randomly selects 10% of cases Non biased controll of data entry Will indentify: errors of data entry, interpretation or coding and errors of intention Will increase credibility and scientific value